Potential of bone marrow stromal cells in applications for neuro-degenerative, neuro-traumatic and muscle degenerative diseases

Mari Dezawa, Hiroto Ishikawa, Mikio Hoshino, Yutaka Itokazu, Yo Ichi Nabeshima

Research output: Contribution to journalReview article

36 Citations (Scopus)

Abstract

Cell transplantation is a promising strategy for the treatment of neurodegenerative and muscle degenerative diseases. Many kinds of cells, including embryonic stem cells and tissue stem cells, have been considered as candidates for transplantation therapy. Bone marrow stromal cells (MSCs) have great potential as therapeutic agents since they are easy to isolate and can be expanded from patients without serious ethical or technical problems. We discovered a new method for the highly efficient and specific induction of functional Schwann cells, neurons and skeletal muscle lineage cells from both rat and human MSCs. These induced cells were transplanted into animal models of neurotraumatic injuries, Parkinson's disease, stroke and muscle dystrophies, resulting in the successful integration of transplanted cells and an improvement in behavior of the transplanted animals. Here we focus on the respective potentials of MSC-derived cells and discuss the possibility of clinical application in degenerative diseases.

Original languageEnglish (US)
Pages (from-to)257-266
Number of pages10
JournalCurrent Neuropharmacology
Volume3
Issue number4
DOIs
StatePublished - Oct 1 2005

Fingerprint

Mesenchymal Stromal Cells
Muscles
Stromal Cells
Bone Marrow
Animal Behavior
Schwann Cells
Cell Transplantation
Embryonic Stem Cells
Muscle Cells
Parkinson Disease
Skeletal Muscle
Stem Cells
Therapeutics
Animal Models
Transplantation
Stroke
Neurons
Wounds and Injuries

Keywords

  • Cell therapy
  • Mesenchymal cell
  • Myogenic differentiation
  • Neuronal differentiation
  • Regenerative medicine
  • Schwann cells
  • Transdifferentiation
  • Transplantation

ASJC Scopus subject areas

  • Pharmacology
  • Neurology
  • Clinical Neurology
  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

Potential of bone marrow stromal cells in applications for neuro-degenerative, neuro-traumatic and muscle degenerative diseases. / Dezawa, Mari; Ishikawa, Hiroto; Hoshino, Mikio; Itokazu, Yutaka; Nabeshima, Yo Ichi.

In: Current Neuropharmacology, Vol. 3, No. 4, 01.10.2005, p. 257-266.

Research output: Contribution to journalReview article

Dezawa, Mari ; Ishikawa, Hiroto ; Hoshino, Mikio ; Itokazu, Yutaka ; Nabeshima, Yo Ichi. / Potential of bone marrow stromal cells in applications for neuro-degenerative, neuro-traumatic and muscle degenerative diseases. In: Current Neuropharmacology. 2005 ; Vol. 3, No. 4. pp. 257-266.
@article{5c27ae136ef44d18a346cbd4c53232fd,
title = "Potential of bone marrow stromal cells in applications for neuro-degenerative, neuro-traumatic and muscle degenerative diseases",
abstract = "Cell transplantation is a promising strategy for the treatment of neurodegenerative and muscle degenerative diseases. Many kinds of cells, including embryonic stem cells and tissue stem cells, have been considered as candidates for transplantation therapy. Bone marrow stromal cells (MSCs) have great potential as therapeutic agents since they are easy to isolate and can be expanded from patients without serious ethical or technical problems. We discovered a new method for the highly efficient and specific induction of functional Schwann cells, neurons and skeletal muscle lineage cells from both rat and human MSCs. These induced cells were transplanted into animal models of neurotraumatic injuries, Parkinson's disease, stroke and muscle dystrophies, resulting in the successful integration of transplanted cells and an improvement in behavior of the transplanted animals. Here we focus on the respective potentials of MSC-derived cells and discuss the possibility of clinical application in degenerative diseases.",
keywords = "Cell therapy, Mesenchymal cell, Myogenic differentiation, Neuronal differentiation, Regenerative medicine, Schwann cells, Transdifferentiation, Transplantation",
author = "Mari Dezawa and Hiroto Ishikawa and Mikio Hoshino and Yutaka Itokazu and Nabeshima, {Yo Ichi}",
year = "2005",
month = "10",
day = "1",
doi = "10.2174/157015905774322507",
language = "English (US)",
volume = "3",
pages = "257--266",
journal = "Current Neuropharmacology",
issn = "1570-159X",
publisher = "Bentham Science Publishers B.V.",
number = "4",

}

TY - JOUR

T1 - Potential of bone marrow stromal cells in applications for neuro-degenerative, neuro-traumatic and muscle degenerative diseases

AU - Dezawa, Mari

AU - Ishikawa, Hiroto

AU - Hoshino, Mikio

AU - Itokazu, Yutaka

AU - Nabeshima, Yo Ichi

PY - 2005/10/1

Y1 - 2005/10/1

N2 - Cell transplantation is a promising strategy for the treatment of neurodegenerative and muscle degenerative diseases. Many kinds of cells, including embryonic stem cells and tissue stem cells, have been considered as candidates for transplantation therapy. Bone marrow stromal cells (MSCs) have great potential as therapeutic agents since they are easy to isolate and can be expanded from patients without serious ethical or technical problems. We discovered a new method for the highly efficient and specific induction of functional Schwann cells, neurons and skeletal muscle lineage cells from both rat and human MSCs. These induced cells were transplanted into animal models of neurotraumatic injuries, Parkinson's disease, stroke and muscle dystrophies, resulting in the successful integration of transplanted cells and an improvement in behavior of the transplanted animals. Here we focus on the respective potentials of MSC-derived cells and discuss the possibility of clinical application in degenerative diseases.

AB - Cell transplantation is a promising strategy for the treatment of neurodegenerative and muscle degenerative diseases. Many kinds of cells, including embryonic stem cells and tissue stem cells, have been considered as candidates for transplantation therapy. Bone marrow stromal cells (MSCs) have great potential as therapeutic agents since they are easy to isolate and can be expanded from patients without serious ethical or technical problems. We discovered a new method for the highly efficient and specific induction of functional Schwann cells, neurons and skeletal muscle lineage cells from both rat and human MSCs. These induced cells were transplanted into animal models of neurotraumatic injuries, Parkinson's disease, stroke and muscle dystrophies, resulting in the successful integration of transplanted cells and an improvement in behavior of the transplanted animals. Here we focus on the respective potentials of MSC-derived cells and discuss the possibility of clinical application in degenerative diseases.

KW - Cell therapy

KW - Mesenchymal cell

KW - Myogenic differentiation

KW - Neuronal differentiation

KW - Regenerative medicine

KW - Schwann cells

KW - Transdifferentiation

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=26844489638&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=26844489638&partnerID=8YFLogxK

U2 - 10.2174/157015905774322507

DO - 10.2174/157015905774322507

M3 - Review article

C2 - 18369401

AN - SCOPUS:26844489638

VL - 3

SP - 257

EP - 266

JO - Current Neuropharmacology

JF - Current Neuropharmacology

SN - 1570-159X

IS - 4

ER -